Revive Therapeutics Files Business Acquisition Report

February 08, 2021 | Last Trade: C$0.02 0.00 0.00

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE:RVV) (USA: RVVTF), announces that it has filed a Form 51-102F4 Business Acquisition Report (BAR) pursuant to National Instrument 51-102 Continuous Disclosure Obligations in connection with its acquisition of Psilocin Pharma Corp. on March 5, 2020.‎ The BAR has been filed as a result of a review conducted by staff at the Ontario Securities Commission in connection with the Company’s recently filed preliminary short form prospectus dated January 26, 2021.

For more information, please contact:

Michael Frank
Chief Executive Officer
Revive Therapeutics Ltd.
Tel: 1 888 901 0036
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Website: www.revivethera.com

Stock Quote

Last Trade:	C$0.02
Daily Volume:	1,010,850
Market Cap:	C$8.370M

June 26, 2025 Revive Therapeutics Nears Completion of Key Nerve Agent Countermeasure Study with Canadian Department of National Defence Highlighting Significant Stockpiling Opportunity June 04, 2025 Revive Therapeutics Advances with Next-Generation Bucillamine Development May 12, 2025 Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure April 10, 2025 Revive Therapeutics to Investigate Bucillamine’s Potential in Cancer Treatment April 01, 2025 Revive Therapeutics Announces Acquisition of Molecular Hydrogen Program LOAD MORE NEWS

Featured Stock

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

Featured Stock

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE